NEXGEL, Inc.
NEXGEL, Inc. (NXGL) Financial Performance & Income Statement Overview
Review NEXGEL, Inc. (NXGL) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
NEXGEL, Inc. (NXGL) Income Statement & Financial Overview
Explore comprehensive income reports for NEXGEL, Inc. NXGL, broken down by year and quarter.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $3.04M | $2.94M | $1.44M | $1.27M |
Cost of Revenue | $2.26M | $1.66M | $1.03M | $1.02M |
Gross Profit | $779000.00 | $1.28M | $410000.00 | $246000.00 |
Gross Profit Ratio | $0.26 | $0.44 | $0.28 | $0.19 |
R&D Expenses | $0.00 | $0.00 | $76000.00 | $2000.00 |
SG&A Expenses | $1.53M | $2.07M | $1.39M | $1.11M |
Operating Expenses | $1.62M | $2.07M | $1.46M | $1.12M |
Total Costs & Expenses | $3.88M | $3.73M | $2.49M | $2.14M |
Interest Income | $0.00 | $0.00 | $1000.00 | $0.00 |
Interest Expense | $16000.00 | $20000.00 | $30000.00 | $15000.00 |
Depreciation & Amortization | $150000.00 | $184000.00 | $86000.00 | $114000.00 |
EBITDA | -$698000.00 | -$554000.00 | -$863000.00 | -$776000.00 |
EBITDA Ratio | -$0.23 | -$0.19 | -$0.60 | -$0.61 |
Operating Income | -$841000.00 | -$788000.00 | -$1.05M | -$871000.00 |
Operating Income Ratio | -$0.28 | -$0.27 | -$0.73 | -$0.69 |
Other Income/Expenses (Net) | $17000.00 | $34000.00 | $75000.00 | -$34000.00 |
Income Before Tax | -$824000.00 | -$754000.00 | -$979000.00 | -$905000.00 |
Income Before Tax Ratio | -$0.27 | -$0.26 | -$0.68 | -$0.71 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | -$52000.00 |
Net Income | -$850000.00 | -$693000.00 | -$885000.00 | -$853000.00 |
Net Income Ratio | -$0.28 | -$0.24 | -$0.61 | -$0.67 |
EPS | -$0.13 | -$0.11 | -$0.14 | -$0.14 |
Diluted EPS | -$0.13 | -$0.11 | -$0.14 | -$0.14 |
Weighted Avg Shares Outstanding | $7.30M | $6.57M | $6.25M | $5.98M |
Weighted Avg Shares Outstanding (Diluted) | $7.30M | $6.57M | $6.25M | $5.98M |
The company's financials show resilient growth, with revenue advancing from $1.27M in Q1 2024 to $3.04M in Q4 2024. Gross profit remained healthy with margins at 26% in Q4 2024 compared to 19% in Q1 2024. Operating income hit -$841000.00 last quarter, sustaining a consistent -28% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$698000.00. Net income dropped to -$850000.00, while earnings per share reached -$0.13. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan